AA
ADAP
AlphaCentric Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-68,500
| Closed | -$354K | – | 222 |
|
|
2021
Q3 | $354K | Sell |
68,500
-51,500
| -43% | -$266K | 0.09% | 84 |
|
|
2021
Q2 | $511K | Buy |
120,000
+69,000
| +135% | +$294K | 0.14% | 61 |
|
|
2021
Q1 | $271K | Buy |
51,000
+7,000
| +16% | +$37.2K | 0.09% | 80 |
|
|
2020
Q4 | $237K | Buy |
44,000
+39,800
| +948% | +$214K | 0.1% | 59 |
|
|
2020
Q3 | $34K | Buy |
4,200
+2,400
| +133% | +$19.4K | 0.02% | 126 |
|
|
2020
Q2 | $18K | Buy |
+1,800
| New | +$18K | 0.01% | 124 |
|